Status:
COMPLETED
In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients
Lead Sponsor:
Duke University
Conditions:
Stem Cell Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hematopoietic stem cell transplant (HCT) is an aggressive treatment for life-threatening cancers. HCT improves survival, but most HCT patients experience significant physical disability, which is exac...
Eligibility Criteria
Inclusion
- Hematopoietic stem cell transplant due to oncological disease
- Clinical ratings of pain, fatigue and psychological distress
- Life expectancy of 12 or more months
Exclusion
- Cognitive impairment
- Severe psychiatric condition
- Inability to converse in English
Key Trial Info
Start Date :
July 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03859765
Start Date
July 23 2019
End Date
December 20 2021
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Institute
Durham, North Carolina, United States, 27701